Background. Cytokines are key regulators of measles vaccine humoral and cellular immunity. Single-nucleotide polymorphisms (SNPs) that are associated with differences in cytokine levels should also influence measles vaccineinduced immunity.
erated after MMR vaccination vary from individual to individual. Several studies, including our own, have shown that 2%-10% of healthy vaccinees do not produce protective levels of measles antibodies [4] [5] [6] . Furthermore, waning measles antibody responses have been observed in vaccinated individuals, and it has been established that the risk of mild or subclinical measles infection is higher in individuals with sufficiently low levels of measles-specific antibodies [7, 8] . Variations in the immune response to measles vaccine has been attributed in part to the polymorphic HLA genes, which play an important role in antigen processing and presentation [9] [10] [11] . However, HLA polymorphisms alone do not account for all variations in the immune response to vaccines. For example, in the case of hepatitis B virus (HBV) vaccine, cytokine and HLA polymorphisms were found to be independently associated with variations in immune responses [12] . In addition, other factors-such as the repertoire of antigen-presenting cells, cytokine-secretion profiles, and the relative contribution of the Th1 and Th2 cytokine-secreting subsets to the effector immune response-may also result in interindividual variation in immune responses [13, 14] .
Cytokines are important regulators of immune responses to both measles infection and vaccination [14] [15] [16] [17] . During the rash phase of measles infection, there is a preferential activation of the Th1 subset that is characterized by increased secretion of interleukin (IL)-2 and interferon (IFN)-g, followed by activation of the Th2 subset during the convalescent phase that is characterized by increased IL-4 production and decreased levels of Th1 cytokines [15, 18] . Measles vaccination has been reported to induce a balanced cytokine milieu of both Th1 and Th2 cytokines in the majority of vacinees [17, 19] . Thus, the genetic background of the cytokine pool in response to measles vaccine may contribute to variations in immune response, because the genes encoding these cytokines and their corresponding receptors have polymorphic forms. Polymorphisms, specifically those in coding and promoter regions, may be functionally important and may result in variation in immune responses to measles vaccination.
In the present hypothesis-generating study, we evaluated associations between measures of immunity (humoral and cellular) and single-nucleotide polymorphisms (SNPs) of Th1/Th2 (IFN-g, IL-2, IL-4, IL-10, and IL-12p40) cytokine and cytokinereceptor genes likely to regulate variations in immune response after 2 doses of MMR vaccine in a healthy population.
SUBJECTS, MATERIALS, AND METHODS
Study population and subject characterization. The present study was based on a previously recruited cohort of randomly selected Olmsted County schoolchildren ( ) between 12 n p 346 and 18 years old who had been immunized with 2 doses of MMR vaccine. The details of subject recruitment and characterization of the study cohort have been published elsewhere [20, 21] .
Budget constraints did not allow us to genotype all 346 children. In an attempt to maximize variations in humoral and cell-mediated immunity across individuals, we categorized the children into "extreme" immune-response quadrants: high antibody and high cellular response (Ab high CMI high ), low antibody and high cellular response (Ab low CMI high ), low antibody and low cellular response (Ab low CMI low ), and high antibody and low cellular response (Ab high CMI low ) (figure 1). To define the quadrants, the data were first plotted in a scatter diagram. After the transformations that normalized the measurements were identified, quadrants were formed. The squared distance from the intersection of the 2 median lines to the observed pair of transformed measurements was obtained for each subject. Subjects were then sorted according to these distances, and the 30 subjects with the largest distances in each quadrant were selected.
Secreted cytokines. Peripheral blood mononuclear cells (PBMCs) from each subject were cultured with or without measles virus (MOI, 0.5), and culture supernatants were monitored for secreted IFN-g, IL-2, IL-10, and IL-12p40 [9] . IL-4 was assayed using cell culture conditions modified by the addition of IL-4R antibody in addition to measles virus (MOI, 0.1) [22] . Selection of cytokine and cytokine-receptor SNPs. SNPs were selected on the basis of an extensive literature search and review of the SNP500Cancer database (available at: http:// snp500cancer.nci.nih.gov/home_1.cfm) and the National Center for Biotechnology Information SNP database (available at: http://www.ncbi.nlm.nih.gov/projects/SNP/). SNPs were shortlisted on the basis of their functional-disease association, frequency in the white population (minor allele frequency, 15%), and location within each gene (coding: synonymous or nonsynonymous and 5 or 3 untranslated regions or introns). The nomenclature used for the description of the variants was described by den Dunnen and Antonarakis [23] .
Genotyping methods. We extracted genomic DNA from clotted blood using the Puregene extraction kit (Gentra Systems). Multiplex polymerase chain reaction (PCR) and SNP analyses were performed using the GenomeLab SNPstream platform (Beckman Coulter). Primer sets for PCR and tagged single base extension for SNPstream assays were designed using Autoprimer software (Beckman Coulter; available at: http:// www.autoprimer.com). After PCR in 12-plex reactions, the tagged extension primers were extended with single TAMRAor BODIPY-fluorescein-labeled nucleotide terminator reactions and then hybridized to the complementary oligonucleotides arrayed on SNPware 384-well Tag array plates. These plates were imaged using the GenomeLab SNPstream array imager, and the resulting data were processed using the SNPstream imaging software (version 2.2.55; GenomeLab). All SNP data were reviewed by graphical cluster and Hardy-Weinberg equilibrium (HWE) analysis.
The individual SNPs were identified by their position within clusters and fluorescent color in each well according to the position of the tagged oligonucleotides. Genotype data for individual samples were generated on the basis of the relative fluorescent intensities for each SNP and processed by computer for graphical review. Controls included 2 genomic DNAs, each with 8 replicates per 384-well plate and 8 replicates without DNA. Call rates for each SNP ranged between 90% and 99.3%. The 3 SNPs that failed the SNPstream platform were genotyped using pyrosequencing.
Genotyping for IFN-g CA repeats and IL10.G-microsatellite polymorphisms was performed on an Applied Biosystems 3100 DNA sequencer. Briefly, 10 ng of genomic DNA was amplified in a PCR using fluorescently labeled primers in the presence of TaqGold enzyme (Applied Biotechnology). The primer sequences for IFN-g CA repeats and IL10.G-microsatellite polymorphisms were IFN-g forward, 5 -GACATTCACAATTGATTTTATTCT-TAC-3 , and IFN-g reverse, 5 -GCCTTCCTGTAGGGTATTAT-TATAC-3 ; and IL10.G forward, 5 -GTCCTTCCCCAGGTA-GAG-3 , and IL10.G reverse, 5 -TTGGATTAAATTGGCCTT-AGA-3 . After denaturing and activation for 15 min at 95ЊC, 35 cycles of PCR at an annealing temperature of 50ЊC were performed, with a final extension of 7 min at 72ЊC. The genotyping data were analyzed using Genotyper software (version 3.7; Applied Biosystems). Controls included 2 genomic DNAs, each in duplicate 96-well plates, and 2 wells without DNA. Five different IFN-g alleles were identified. These alleles contained a sequence ranging from 11 CA repeats (127 bp) to 15 CA repeats (135 bp). Nine different IL10.G-microsatellite alleles were identified, ranging from 299 to 315 bp.
Statistical methods. Data were summarized using frequencies and percentages for all categorical variables and medians and interquartile ranges for all continuous variables. Cytokine and cytokine-receptor SNPs were examined on a genotypic level, using 3 categories to describe each SNP: homozygous major and heterozygous or homozygous minor alleles. We tested each SNP for departure from HWE using x 2 goodnessof-fit tests [24] .
Associations between cytokine and cytokine-receptor SNPs and measles virus-induced cellular and humoral immune responses were initially assessed using x 2 tests of significance that compared the distribution of the SNPs across the antibodyand stimulation index (SI)-defined quadrants. Two sets of comparisons were made: one that assessed differences among all 4 quadrants, and one that made comparisons between the 2 extreme concordance quadrants (high antibody and high lymphoproliferative responses vs. low antibody and low lymphoproliferative responses). Subsequent analyses accounting for the effects of potential confounding variables associated with immune response were performed using logistic-regression analyses appropriate for response variables with 12 categories [25] . The following variables were included in such models: age at enrollment, sex, race, age at the first MMR vaccination, and age at the second MMR vaccination. Because of small sample sizes and the polymorphic nature of the HLA system, it was not possible to adjust for the effects of HLA type.
Associations between the cytokine and cytokine-receptor SNPs and measles virus-stimulated cytokine secretion levels were performed using analysis of covariance. Because of data skewing, all P values were calculated using rank-transformed secretion values. Initial analyses accounted only for the antibody and SI-derived quadrant design variable. Subsequent models also adjusted for the effects of the same set of potential confounding variables listed above. All statistical tests were 2-sided, and all analyses were performed using SAS software (version 9.0; SAS Institute).
RESULTS

Demographics.
The demographic characteristics of the cohort have been described in detail elsewhere [21, 26] . Briefly, the majority of the cohort was white (93%), with near-equal representation of the sexes, and all children had been immunized with the age-recommended 2-dose MMR vaccine. The median age at the first and second immunization was 15.6 months and 12.1 years, respectively. Cellular and humoral immune responses. The joint distribution of measles-specific antibody and lymphoproliferative response among the 346 original subjects is shown in figure 1 . On the basis of the manufacturer's criteria for measles antibody assays, we had 85.6% seropositive, 12.7% seroequivocal, and 1.7% seronegative study subjects (N.D., I.G.O., J. E. Ryan, R.M.J., R.A.V., V.S.P., S. J. Jacobsen, and G.A.P., unpublished data). On the basis of criteria of an SI у3 for a positive lymphoproliferative response, we obtained a positive lymphoproliferative response rate of 62.4% to measles vaccine [21] . On the basis of measles-specific antibody and lymphoproliferative response values, we selected our final study subjects from the empirically defined quadrants. The median (range) of measlesspecific antibody and SI responses in the immune response quadrants was as follows: Ab high CMI high , 4314 IU/mL (2963-5326 IU/mL) and 12.6 (7.7-20.1); Ab low CMI high , 474 IU/mL (355-700 IU/mL) and 8.4 (6.1-12.0); Ab low CMI low , 342 IU/mL (258-533 IU/mL) and 1.5 (1.1-1.8); and Ab high CMI low , 3875 IU/ mL (2498-4956 IU/mL) and 1.6 (0.9-1.8), respectively. The overall levels of cytokine secretion detected in our 118 study subjects are summarized in table 1. We readily detected IFNg, IL-4, IL-10, and IL-12p40 secretion in culture supernatants from PBMCs in 180% of study subjects, whereas the proportion of subjects with detectable secreted IL-2 was low (43%). The frequencies of genetic variants of the common cytokine and cytokine SNPs in the population cohort analyzed in the study are shown in table 2 Associations between Th1/Th2 cytokine and cytokine-receptor SNPs and immune responses after measles vaccination. We found several significant associations ( ) between SNPs P ! .05 in the IL-2, IL-10, and IL-12B genes and measures of measles vaccine immunity (table 3) . The Ϫ330G and Ϫ34G variants within the IL-2 gene were associated with high antibody and high lymphoproliferative responses to measles. Three intronic SNPs in the IL-10 gene were associated with low antibody and low lymphoproliferative responses to measles. In addition, minor alleles in the IL-12Bp40 gene varied significantly ( ) P ! .05 across the quadrants for immune responses. Furthermore, strong linkage disequilibrium ( ) was seen in SNPs in the IL-2 r p 1.0 10 (rs1800871 and rs1800872) and IL-12Bp40 (rs2421047 and rs3212227) genes.
Among the SNPs for cytokine-receptor genes, we found significant associations ( ) between SNPs in the IL-4RA and P ! .05 IL-12RB genes and measures of measles vaccine immunity (table 4). Two intronic SNPs in the IL-12 receptor gene were associated with low antibody and low lymphoproliferative responses to measles virus. In addition, a nonsynonymous SNP (isoleucinerphenylalanine at position 75) in the IL-4RA gene varied significantly ( ) across the quadrants for immune P ! .05 responses.
Associations between secreted cytokine levels and SNPs. Significant associations were found between cytokine and cytokine-receptor SNPs and levels of secreted cytokines (table 5) . The most striking associations were found between IL-4R polymorphisms and levels of secreted IL-4. Major alleles for 4 SNPs in the IL-4R gene were found to be significantly ( ) as-P ! .05 sociated with low levels of secreted IL-4. However, 3 of these 4 SNPs in the IL-4R gene (rs1805011, rs1805012, and rs2234898) were in tight linkage disequilibrium ( ).
2 r p 0.93 We also observed some cross-regulation of secreted IFN-g, IL-2, IL-4, IL-10, and IL-12p40 levels by SNPs found in the IFN-g, IL-10, IL-12A, and IL-12B cytokine genes and the IL- 2RA, IL-4RA, and IL-12RB cytokine-receptor genes. All of the associations reported above were reassessed after adjustment for the effects of age at enrollment, sex, race, and age at first and second MMR vaccinations. The results did not differ substantively from those based on simpler models, which indicates that the reported findings cannot be explained by a possible association with these other factors (data not shown).
DISCUSSION
In the present hypothesis-generating study, we determined the associations between a panel of cytokine and cytokine-receptor SNPs and immune responses to measles vaccine in a population that received 2 doses of MMR vaccine. Our data suggest that certain SNPs in the cytokine and cytokine-receptor genes may be associated with variations in immune response after measles vaccination.
Because cytokines play an essential role in the regulation of humoral and cellular immunity to measles infection and vaccination, polymorphisms that alter cytokine levels or cytokine activity influence the outcome of the immune response. Other researchers have reported that cytokines and cytokine receptors are target immune-function genes for association studies of disease susceptibility and progression [12, [27] [28] [29] [30] . Therefore, population-based association studies of variations in immune responses to vaccines and genetic variants of cytokine and cytokine receptor genes could provide key information about the function and molecular role of cytokines in vaccine-induced immunity.
The present study has demonstrated that polymorphisms in the IL-2, IL-10, and IL-12RB genes are associated with variations in the immune response to measles vaccination. The associations of cytokines with the extremes of the cellular and humoral immune-response spectra to measles vaccination found in our study may have a functional mechanism. For example, IL-2 is a key Th1 cytokine involved in early CD4 and CD8 T cell activation and selective expansion through the expression of IL-2 receptors [31] . It is involved in NK cell proliferation and indirectly modulates antibody synthesis via B cell prolif- eration and enhancing antibody secretion [31] . It has also been reported that IL-2 is involved in the early type 1 response to measles infection and vaccination and that it is predominantly produced by CD4 T cells [14, 32] . Our study demonstrates that 2 polymorphisms in the IL-2 gene-rs2069762 (IVS1-100 [GrT], aka Ϫ330) in the promoter region and a synonymous change at aa 38 (L38L) within exon 2, rs2069763 (Ex2-34 [GrT])-are associated with variable immune responses to measles vaccination. Both of the variants resulted in higher antibody and lymphoproliferative responses to measles vaccination. Previously, it was demonstrated that genetic variations in IL-2 genes, such as the IVS1-100G variant, enhance IL-2 production in cell cultures [33] . Importantly, this variant has also been reported to be associated with the responder phenotype after full-dose HBV vaccination [12] .
Similarly, 3 variations in the IL-10 gene at positions Ϫ626A (rs1800872, aka Ϫ592A), Ϫ853T (rs1800871, aka Ϫ819T), and Ϫ3584A (rs1800890) were found to be associated with variable immune responses to measles vaccination. IL-10 is produced by Th2 cells, monocytes, macrophages, and other regulatory T cells, and it is known to inhibit HLA class I expression and the production of proinflammatory cytokines such as IL-1a, IL1b, IL-6, IL-8, IL-12, tumor necrosis factor-a, and IFN-g [34] . Several polymorphisms have been identified in distal (Ϫ2 and Ϫ4 kb) and proximal (up to Ϫ2kb) promoter regions of the IL-10 gene, and their haplotypes have been described [35, 36] . Furthermore, it has been demonstrated that SNPs located in the proximal promoter region of the IL-10 gene, such as Ϫ1116G (rs1800896, aka Ϫ1082G) and Ϫ853T and Ϫ626A, are associated with lower production of secreted IL-10 [35, 37] . We have demonstrated that the Ϫ853T and Ϫ626A alleles, which are in perfect linkage disequilibrium with each other, are associated with high levels of cellular and humoral immunity to measles vaccination, which is suggestive of a balanced Th1/ Th2 activation in response to low IL-10 production in subjects carrying these alleles. In addition, a distal promoter Ϫ3584T allele was also associated with high levels of immune response to measles vaccination. Associations between IL-10 microsatellites or promoter-region SNPs and both susceptibility to and severity of viral disease are well known [29, 38, 39] . The Ϫ1116GG and Ϫ626AA genotypes are associated with a higher severity of pneumonia, and subjects homozygous for these alleles have a higher mortality rate [40, 41] . The Ϫ1116G allele is known to protect against Epstein-Barr virus infection by an as-yet-unknown mechanism [42] . The function of IL-10 polymorphisms has also been studied in other viral infectionssuch as with cytomegalovirus, herpes zoster virus, herpes simplex virus, HBV, hepatitis C virus, and HIV-and the Ϫ1116G and Ϫ626A alleles have been reported to influence susceptibility, disease severity, and the response to therapy in these diseases [12, 39, 43, 44] . We did not find any association between the Ϫ1116G allele and immune responses to measles vaccination, which is in agreement with the findings of studies of HBV vaccination [12] . In addition, 2 intronic SNPs in the IL-12 receptor were associated with low antibody and low lymphoproliferative responses to measles vaccination, and 2 nonsynonymous variations in the IL-4RA gene and 3 intronic SNPs in the IL-12B gene were associated with the spectrum of immune measures to measles. The mechanism underlying the association between intronic SNPs and the immune response remains unknown.
The influence of cytokine and cytokine-receptor SNPs on the immune response to measles vaccination has not been studied in the past. To our knowledge, Inoue et al. [27] were the first to demonstrate the potential role of the IL-4 Ϫ588T (aka Ϫ589 or rs2243250) allele in conferring susceptibility to subacute sclerosing panencephalitis in a Japanese population. However, we did not find any association between this allele and immune responses to measles vaccination. The reason, in part, may be that our study cohort was primarily white, and it is a P values were calculated on the basis of rank-based data using analysis of covariance, adjusting for antibody and lymphoproliferative response-defined quadrants, to account for the sampling design. b rs1805011, rs1805012, and rs2234898 are in linkage disequilibrium (r well known that host genetic factors vary significantly across populations with different ethnic backgrounds. Finally, we also assessed the influence of cytokine and cytokine-receptor SNPs on levels of individual secreted cytokines in response to measles vaccination. Several synonymous and nonsynonymous polymorphisms in the IL-4RA receptor influenced levels of secreted IL-4, IL-10, and IL-12. We speculate that these polymorphisms and the subsequent amino acid changes in the case of nonsynonymous polymorphisms can change the conformation and, hence, IL-4 uptake and regulation in the cells. This may indirectly affect the cytokine milieu of the host cell and influence measurable levels of other cytokines. The presence of polymorphisms in cytokine genes has been reported to profoundly influence the expression of secreted cytokines [33, 35, 37] . Notably, two-thirds of the SNPs associated with differences in cytokine expression levels were located in receptors for other cytokines. For example, SNPs in the receptors for IL-2, IL-4, and IL-12 were associated with the differential secretion of IL-10. Many cytokines have regulatory effects that promote or block the expression of other cytokines. This observation was previously well documented in the case of several Th1/Th2 cytokines [45, 46] .
The major strength of our study is that our population was sampled from Olmsted County, Minnesota, which has exceedingly high vaccine coverage and no circulating wild-type measles virus. Thus, we are confident that the immune measures reflected vaccination alone and not disease. Furthermore, our study subjects were primarily non-Hispanic whites, which is representative of the US white population [47] . However, the observed associations between measles vaccine-induced immunity and cytokine and cytokine-receptor polymorphisms cannot be extrapolated to other ethnic groups. Several limitations should be noted as well. We had a limited sample size; therefore, it is possible that important associations may have been missed because of the limitations in power resulting from a relatively small sample size. Therefore, we reported all tests that reached the .05 level of significance in deference to this possibility of false-negative results. This led to a second limitation. We assessed associations between a large number of SNPs and several different measures of the immune response, so multiple testing issues are a legitimate concern. We examined a total of 58 SNPs that met HWE assumptions, each on a set of 6 different immune responses, for a total of 348 statistical tests. Under the assumption of the independence of statistical tests, which is not true in studies such as this because of linkage disequilibrium, and using a significance level of .05, we would expect ∼17 tests to be statistically significant on the basis of chance alone. We found 7 significant results when we examined distributions of SNPs across the 4 antibody and lymphoproliferative response quadrants and another 7 significant results when we considered only the concordant quadrants Ab high CMI high and Ab low CMI low . This, coupled with the 15 significant results found across the 5 different measures of cytokine response, resulted in a total of 22 significant tests, regardless of whether all quadrants were considered or just the 2 most extreme quadrants. This number is slightly higher than that expected by chance, which further indicates a possible genetic component to the measles vaccine-induced immune response. However, studies with larger sample sizes must be performed to confirm these results [48] .
In conclusion, multiple host genetic factors contribute to variation in immune responses to measles vaccination. Cytokine and cytokine-receptor polymorphisms may be significant contributing factors to vaccine responsiveness, and our data suggest a possible involvement of genetic variation in the IL-2, IL-10, and IL-12RB genes in measles vaccine-induced immunity. Furthermore, it will be of interest to study the influence of extended haplotypes and heterozygosity at cytokine gene loci on measles-specific immune responses. Complete understanding of the genetic determinants of measles immunity will help inform the development of novel vaccines against measles in combination with immunomodulatory cytokines to overcome suboptimal response to measles vaccination.
